Yigla M, Sprecher E, Azzam Z, Guralnik L, Kapeliovich M, Krivoy N
Division of Pulmonary Medicine, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Respiration. 2000;67(4):445-8. doi: 10.1159/000029546.
We describe a 66-year-old patient with hemoptysis, a drop in hematocrit, hypoxemia and new bilateral alveolar infiltrates after receiving streptokinase for acute myocardial infarction. Markedly increased carbon monoxide diffusion capacity suggested a diagnosis of alveolar hemorrhage. Underlying conditions included congestive heart failure. The patient recovered uneventfully within 7 days of conservative treatment. Alveolar hemorrhage is a rare and often unrecognized life-threatening complication of thrombolytic therapy. Particular attention should be paid to the pulmonary status of patients with congestive heart failure scheduled to receive thrombolytic therapy.
我们描述了一名66岁的患者，在接受链激酶治疗急性心肌梗死后出现咯血、血细胞比容下降、低氧血症以及新出现的双侧肺泡浸润。一氧化碳弥散能力显著增加提示肺泡出血的诊断。基础疾病包括充血性心力衰竭。该患者在保守治疗7天内顺利康复。肺泡出血是溶栓治疗罕见且常未被认识到的危及生命的并发症。对于计划接受溶栓治疗的充血性心力衰竭患者的肺部状况应给予特别关注。
